Manwin to Accept TTS Results

LUXEMBOURG — Following its new health standards and procedures mandate, Manwin will again accept performer submitted health tests from Talent Testing Service Inc.

As previously announced, and as of July 1, Manwin requires FDA approved tests, namely the HIV-1 Aptima RNA Qualitive Assay. The tests must originate from the clinics listed on the APHSS.org website as well as TTS.

"In addition, adult entertainers performing in scenes commissioned for Manwin websites are obliged to provide health tests that are no older than 15 days," the company said Tuesday in a statement. "In cases where a performer works for any of the company's brands multiple times in a 30-day period, Manwin will pay for all additional tests, required due to the 15-day testing window, at any of these locations."

"Though TTS is not part of APHSS, Manwin and TTS have come to an agreement which allows TTS to provide performer test results to the APHSS information bank without joining the program."

TTS' Sixto Pacheco said that some tweaks in display of test results were needed to seal the deal with Manwin.

"After discussions with Manwin, it was agreed that a small change on how we display our test results on our side will satisfy Manwin’s concerns and secure their continued acceptance of TTS tests." he said. "These changes make sure that a positive result is not distinguishable from an expired test. We stand by our commitment to provide the 'best in breed' testing methodologies and continue to work with our stakeholders to put performer health and safety first."

Manwin said that the APHSS program only displays availability of a performer based on both 15 days and 28 days testing  cycles. Availability means that a performer has tested clean for HIV, gonorrhea, chlamydia and syphilis. TTS will also work with APHSS, and other testing facilities, to establish joint procedures to follow in case a positive case should arise.

In a statement, Frank L., Manwin, vice president of production said, “Though we support the APHSS guidelines and procedures, we wanted to provide even greater flexibility for performers across the country to perform tests in a most convenient manner. We believe TTS provides great care and services, and are happy it has come to an agreement with APHSS.”

Related:  

Copyright © 2026 Adnet Media. All Rights Reserved. XBIZ is a trademark of Adnet Media.
Reproduction in whole or in part in any form or medium without express written permission is prohibited.

More News

Angela White Returns to Jules Jordan

Angela White returns to Jules Jordan Video alongside Victor Ray in "The Battle for Sexual Supremacy."

Violet Voss on Parlaying Her Fetish Roots Into a Breakout Year

The term “raven-haired beauty” may have become somewhat of a cliché, but every now and then, a star comes along who truly fits the bill. Performer and fetish creator Violet Voss is just such a presence.

Adult Time Drops Latest Installment of Jim Powers' 'MILF Overload'

Adult Time has released the latest installment of director Jim Powers' series "MILF Overload."

Goddess Tangent Launches New Site Through Grooby's Blue.xxx

Goddess Tangent has launched her new membership site, TangentOD.com, through Grooby's website management company Blue.xxx.

Keiran Lee Guests on Chaturbate's 'Sex Tales' Podcast

Keiran Lee is the latest guest on Chaturbate’s “Sex Tales” podcast, hosted by Melissa Stratton and Vanniall, and streaming on the company’s “Camming Life” YouTube channel.

Aubrey Kate, Charlotte Sins Star in New Transfixed Release

Aubrey Kate and Charlotte Sins star in the latest release from Transfixed, titled "Saved by the Bolster."

Connie Perignon, Angel Youngs Lead Latest From Jules Jordan

Connie Perignon and Angel Youngs star in the latest release from Jules Jordan.

TTS Opens New Los Angeles Testing Location

Talent Testing Service (TTS) has opened a new Hollywood location in Los Angeles.

Kasey Kei, Emma Rosie Topline Joey Silvera's 'Trans-Active 34'

Kasey Kei and Emma Rosie headline director Joey Silvera’s “Trans-Active 34” from Evil Angel.

Show More